Atopic dermatitis causes lipid accumulation in the liver of NC/Nga mouse

Journal of Clinical Biochemistry and Nutrition

Volumn 50, Issue 2, 2012, Pages 152-157

  Seino, Satoshi ^a   Tanaka, Yurie ^a   Honma, Taro ^a   Yanaka, Miyuki ^a   Sato, Kenta ^a   Shinohara, Nahoko ^a   Ito, Junya ^a   Tsuduki, Tsuyoshi ^a   Nakagawa, Kiyotaka ^a   Miyazawa, Teruo ^a   Ikeda, Ikuo ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Allergy; DNA microarray; Lipid metabolism; Liver; NC Nga

Indexed keywords

PICRYL CHLORIDE; TRIACYLGLYCEROL;

ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DNA MICROARRAY; FATTY ACID OXIDATION; FATTY LIVER; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; LIPID METABOLISM; LIPID STORAGE; MALE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WEIGHT GAIN;

EID: 84863287098     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.11-29     Document Type: Article

References (49)

1. Bray GA, Popkin BM. Dietary fat intake does affect obesity! Am J Clin Nutr 1998; 68: 1157-1173. (Pubitemid 28550944)
2. Nakamura T, Tokunaga K, Shimomura I, et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis 1994; 107: 239-246. (Pubitemid 24206863)
3. Sharabi Y, Eldad A. Nonalcoholic fatty liver disease is associated with hyperlipidemia and obesity. Am J Med 2000; 109: 171.
4. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003; 361: 151-160. (Pubitemid 36092023)
5. Sibbald B, Rink E. Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. Thorax 1991; 46: 895-901.
6. Sears MR. Descriptive epidemiology of asthma. Lancet 1997; 350: 1-4. (Pubitemid 127672105)
7. Yuan XY, Ma HM, Li RZ, Wang RY, Liu W, Guo JY. Topical application of aloperine improves 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice. Eur J Pharmacol 2011; 658: 263-269.
8. Hartgerink-Lutgens I. Vermeeren A, Vuurman E, Kremer B. Disturbed cognitive functions after nasal provocation in patients with seasonal allergic rhinitis. Clin Exp Allergy 2009; 39: 500-508.
9. Schmitt J, Romanos M, Pfennig A, Leopold K, Meurer M. Psychiatric comorbidity in adult eczema. Br J Dermatol 2009; 161: 878-883.
10. Sivertsen B, Krokstad S, Øverland S, Mykletun A. The epidemiology of insomnia: associations with physical and mental health. The HUNT-2 study. J Psychosom Res 2009; 67: 109-116.
11. Moreau D, Kalaboka S, Choquet M, Annesi-Maesano I. Asthma, obesity, and eating behaviors according to the diagnostic and statistical manual of mental disorders IV in a large population-based sample of adolescents. Am J Clin Nutr 2009; 89: 1292-1298.
12. Lee HS, Kim SK, Han JB, et al. Inhibitory effects of Rumex japonicus Houtt. on the development of atopic dermatitis-like skin lesions in NC/Nga mice. Br J Dermatol 2006; 155: 33-38.
13. Matsuoka H, Maki N, Yoshida S, et al. A mouse model of the atopic eczema/ dermatitis syndrome by repeated application of a crude extract of house-dust mite Dermatophagoides farinae. Allergy 2003; 58: 139-145. (Pubitemid 36359833)
14. Vestergaard C, Yoneyama H, Murai M, et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 1999; 104: 1097-1105. (Pubitemid 29536320)
15. Ohmura T, Tsunenari I, Hayashi T, et al. Role of substance P in an NC/Nga mouse model of atopic dermatitis-like disease. Int Arch Allergy Immunol 2004; 133: 389-397. (Pubitemid 38490218)
16. Tsuzuki T, Kawakami Y, Suzuki Y, Abe R, Nakagawa K, Miyazawa T. Intake of conjugated eicosapentaenoic acid suppresses lipid accumulation in liver and epididymal adipose tissue in rats. Lipids 2005; 40: 1117-1123. (Pubitemid 43010566)
17. Tsuzuki T, Tokuyama Y, Igarashi M, Miyazawa T. Tumor growth suppression by alpha-eleostearic acid, a linolenic acid isomer with a conjugated triene system, via lipid peroxidation. Carcinogenesis 2004; 25: 1417-1425. (Pubitemid 39162707)
18. Tsuzuki T, Kawakami Y. Tumor angiogenesis suppression by alpha-eleostearic acid, a linolenic acid isomer with a conjugated triene system, via peroxisome proliferator-activated receptor gamma. Carcinogenesis 2008; 29: 797-806. (Pubitemid 351494168)
19. Tsuzuki T, Kawakami Y, Nakagawa K, Miyazawa T. Conjugated docosahexaenoic acid inhibits lipid accumulation in rats. J Nutr Biochem 2006; 17: 518-524. (Pubitemid 44066763)
20. Kuraishi Y, Nagasawa T, Hayashi K, Satoh M. Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur J Pharmacol 1995; 275: 229-233.
21. Rouser G, Fleischer S, Yamamoto A. Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 1970; 5: 494-496.
22. Tsuzuki T, Kambe T, Shibata A, Kawakami Y, Nakagawa K, Miyazawa T. Conjugated EPA activates mutant p53 via lipid peroxidation and induces p53-dependent apoptosis in DLD-1 colorectal adenocarcinoma human cells. Biochim Biophys Acta 2007; 1771: 20-30.
23. Bunz F, Dutriaux A, Lengauer C, et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998; 282: 1497-1501. (Pubitemid 28538613)
24. Yahagi N, Shimano H, Matsuzaka T, et al. P53 involvement in the pathogenesis of fatty liver disease. J Biol Chem 2004; 279: 20571-20575. (Pubitemid 38656450)
25. Ashcroft M, Kubbutat MH, Vousden KH. Regulation of p53 function and stability by phosphorylation. Mol Cell Biol 1999; 19: 1751-1758. (Pubitemid 29098233)
26. Inoue N, Yahagi N, Yamamoto T, et al. Cyclin-dependent kinase inhibitor, p21WAF1/CIP1, is involved in adipocyte differentiation and hypertrophy, linking to obesity, and insulin resistance. J Biol Chem 2008; 283: 21220-21229.
27. Leu JI, George DL. Hepatic IGFBP1 is a prosurvival factor that binds to BAK, protects the liver from apoptosis, and antagonizes the proapoptotic actions of p53 at mitochondria. Genes Dev 2007; 21: 3095-3109. (Pubitemid 350223527)
28. Hashimoto T, Cook WS, Qi C, Yeldandi AV, Reddy JK, Rao MS. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J Biol Chem 2000; 275: 28918-28928.
29. Russell D, Setchell K. Bile acid biosynthesis. Biochemistry 1992; 31: 4737-4749.
30. Marti O, Marti J, Armario A. Effects of chronic stress on food intake in rats: influence of stressor intensity and duration of daily exposure. Physiol Behav 1994; 55: 747-753. (Pubitemid 24104406)
31. Vallès A, Marti O, Garcia A, Armario A. Single exposure to stressors causes long-lasting, stress-dependent reduction of food intake in rats. Am J Physiol Regul Integr Comp Physiol 2000; 279: R1138-R1144.
32. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 1999; 103: 1489-1498.
33. Rothman DL, Magnusson I, Katz LD, Shulman RG, Shulman GI. Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. Science 1991; 254: 573-576. (Pubitemid 21917377)
34. Fanelli C, Calderone S, Epifano L, et al. Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J Clin Invest 1993; 92: 1617-1622. (Pubitemid 23304522)
35. Gregersen N, Andresen BS, Corydon MJ, et al. Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship. Hum Mutat 2001; 18: 169-189. (Pubitemid 32807897)
36. Johnson D, Shepherd RM, Gill D, Gorman T, Smith DM, Dunne MJ. Glucose-dependent modulation of insulin secretion and intracellular calcium ions by GKA50, a glucokinase activator. Diabetes 2007; 56: 1694-1702. (Pubitemid 46842608)
37. Wheatcroft SB, Kearney MT. IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis. Trends Endocrinol Metab 2009; 20: 153-162.
38. Yabe D, Komuro R, Liang G, Goldstein JL, Brown MS. Liver-specific mRNA for Insig-2 down-regulated by insulin: implications for fatty acid synthesis. Proc Natl Acad Sci USA 2003; 100: 3155-3160. (Pubitemid 36356555)
39. Chida Y, Hamer M, Steptoe A. A bidirectional relationship between psychosocial factors and atopic disorders: a systematic review and metaanalysis. Psychosom Med 2008; 70: 102-116.
40. Shalev AY, Bonne O, Eth S. Treatment of posttraumatic stress disorder: a review. Psychosom Med 1996; 58: 165-182. (Pubitemid 26097169)
41. Kuo LE, Kitlinska JB, Tilan JU, et al. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med 2007; 13: 803-811. (Pubitemid 47038195)
42. Schwartz AR, Gerin W, Davidson KW, et al. Toward a causal model of cardiovascular responses to stress and the development of cardiovascular disease. Psychosom Med 2003; 65: 22-35. (Pubitemid 36143194)
43. Dhabhar FS. Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology. Neuroimmunomodulation 2009; 16: 300-317.
44. Adam TC, Epel ES. Stress, eating and the reward system. Physiol Behav 2007; 91: 449-458. (Pubitemid 47016532)
45. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-1761. (Pubitemid 40385531)
46. Kim WH, Lee JW, Gao B, Jung MH. Synergistic activation of JNK/SAPK induced by TNF-alpha and IFN-gamma: apoptosis of pancreatic beta-cells via the p53 and ROS pathway. Cell Signal 2005; 17: 1516-1532. (Pubitemid 41253991)
47. Chopin V, Slomianny C, Hondermarck H, Le Bourhis. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNFalpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1). Exp Cell Res 2004; 298: 560-573. (Pubitemid 38950871)
48. Kamigaki M, Sakaue S, Tsujino I, et al. Oxidative stress provokes atherogenic changes in adipokine gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2006; 339: 624-632. (Pubitemid 41739713)
49. Tsuduki T, Nakamura Y, Honma T, et al. Intake of 1-deoxynojirimycin suppresses lipid accumulation through activation of the β-oxidation system in rat liver. J Agric Food Chem 2009; 57: 11024-11029.